Please assess the completion status of the following clinical trial:

Trial Title: Lymph Node Mapping in Patients With Endometrial Cancer

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* The patient must be willing and able to provide informed consent~* The patient is willing and able to comply with the study protocol~* The patient has endometrial cancer and is scheduled for robotic hysterectomy and lymphadenectomy~* The patient agrees to follow-up examinations out to 5-years post-treatment~Exclusion Criteria:~* The patient is not a candidate for robotic assisted hysterectomy and lymphadenectomy~* The patient has known or suspected allergies to iodine, indocyanine green (ICG) or isosulfan blue (ISB)~* The patient has hepatic dysfunction confirmed by bilirubin \> 2 x normal (based on reference values from the laboratory used by the patient)

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- sentinel lymph node detection (Type: EXPERIMENTAL): Patients undergo sentinel lymph node detection using fluorescence imaging with indocyanine green solution and isosulfan blue and sentinel lymph node biopsy.

Based on this trial design, predict the completion outcome and termination type (if applicable).